FSCN1 and gastric cancer: In gastric cancer, one study reported that Fas signaling induces FSCN1 expression via the STAT3 pathway [82]; another study demonstrated that galectin-3 regulates the GSK-3β/β-catenin/TCF-4 signaling pathway, thus triggering FSCN1 expression [83] (Figure 1).